Breaking News, Financial News

Financial Report: Bristol-Myers Squibb 3Q08

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bristol-Myers Squibb 3Q Revenues: $5.3 billion (+14%) 3Q Earnings: $2.6 billion (earnings were $858 million in 3Q07) YTD Revenues: $15.3 billion (+17%) YTD Earnings: $4.0 billion (+74%) Comments: Pharmaceutical sales were up 15% to $4.5 billion in the quarter. Growth was driven by strong performance from Plavix, Abilify, the HIV and hepatitis portfolio, as well as Orencia. Plavix sales were $1.4 billion in the quarter (+15%). Abilify sales were $564 million (+34%). Sustiva Franch...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters